Trial Profile
Efficacy of vedolizumab in patients with inflammatory bowel disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Dec 2016
Price :
$35
*
At a glance
- Drugs Vedolizumab (Primary)
- Indications Crohn's disease; Inflammatory bowel diseases; Ulcerative colitis
- Focus Therapeutic Use
- 14 Dec 2016 New trial record
- 19 Oct 2016 Results presented at the 24th United European Gastroenterology Week